InvestorsHub Logo
Followers 42
Posts 5506
Boards Moderated 0
Alias Born 01/28/2010

Re: None

Tuesday, 03/01/2011 10:11:13 AM

Tuesday, March 01, 2011 10:11:13 AM

Post# of 205102
Mabcure, one of ARYC competitors for ovarian and prostate cancer diagnostic tests, just released a corporate update of their progress. Why can't ARYC do the same?

http://www.businesswire.com/news/home/20110301006392/en/MabCure-Corporate-Update